Product Information
METHYLPHENIDATE ER 30 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $2.8775 per EA under NDC 00591387319. Its NADAC has been published 165 times since Dec 21, 2022.
Strength
30 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591387319
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208861On Market Since
9/30/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 30 MG CAP has been published 165 times since Dec 21, 2022, and over the history we have for it it has declined 42.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8775 per EA |
|---|---|
| All-time high | $5.5319 (Apr 10, 2024) |
| All-time low | $2.7352 (May 22, 2024) |
| 52-week high | $2.8775 |
| 52-week low | $2.8775 |
| Median price | $3.0181 |
| Average price | $3.9893 |
| Largest weekly change | -36.0% (Apr 17, 2024) |
| Weeks tracked | 165 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 30 MG CAP, manufactured by Actavis Pharma, Inc., is $2.8775 per EA (NDC 00591387319), effective Feb 11, 2026.
How has the price of METHYLPHENIDATE ER 30 MG CAP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 30 MG CAP has declined 42.1%. It has been tracked across 165 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 30 MG CAP?
Since Dec 21, 2022, the NADAC for METHYLPHENIDATE ER 30 MG CAP has ranged from a low of $2.7352 (May 22, 2024) to a high of $5.5319 (Apr 10, 2024), with a median of $3.0181 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 30 MG CAP?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHYLPHENIDATE CD 30 MG CAP, is $1.8150 per EA — about 37% below METHYLPHENIDATE ER 30 MG CAP.
Who manufactures METHYLPHENIDATE ER 30 MG CAP?
METHYLPHENIDATE ER 30 MG CAP (NDC 00591387319) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification